| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Transplantation | 224 | 2024 | 4185 | 10.780 |
Why?
|
| Graft Rejection | 195 | 2024 | 4370 | 8.800 |
Why?
|
| Isoantibodies | 35 | 2023 | 665 | 4.290 |
Why?
|
| Graft Survival | 91 | 2023 | 3731 | 3.580 |
Why?
|
| Kidney | 106 | 2023 | 7152 | 3.370 |
Why?
|
| Transplantation Tolerance | 29 | 2023 | 616 | 3.170 |
Why?
|
| Nephritis, Interstitial | 19 | 2024 | 155 | 3.070 |
Why?
|
| Complement C4b | 23 | 2023 | 134 | 2.560 |
Why?
|
| Kidney Diseases | 33 | 2023 | 2136 | 2.490 |
Why?
|
| Transplantation, Homologous | 108 | 2023 | 4794 | 2.350 |
Why?
|
| Kidney Glomerulus | 27 | 2020 | 697 | 1.910 |
Why?
|
| Macaca fascicularis | 57 | 2023 | 916 | 1.760 |
Why?
|
| Heart Transplantation | 40 | 2020 | 3123 | 1.700 |
Why?
|
| Transplantation, Heterologous | 38 | 2024 | 2387 | 1.640 |
Why?
|
| Organ Transplantation | 12 | 2022 | 1127 | 1.540 |
Why?
|
| Glomerulonephritis, Membranous | 2 | 2023 | 89 | 1.520 |
Why?
|
| Immune Tolerance | 44 | 2022 | 2275 | 1.400 |
Why?
|
| Kidney Tubules | 20 | 2020 | 477 | 1.370 |
Why?
|
| Fibronectins | 26 | 2004 | 728 | 1.340 |
Why?
|
| Transplantation Chimera | 30 | 2020 | 616 | 1.290 |
Why?
|
| Biopsy | 59 | 2023 | 6771 | 1.270 |
Why?
|
| Bone Marrow Transplantation | 30 | 2020 | 2739 | 1.210 |
Why?
|
| Immunosuppressive Agents | 52 | 2024 | 4121 | 1.200 |
Why?
|
| Antibody Formation | 21 | 2010 | 1407 | 1.160 |
Why?
|
| Killer Cells, Natural | 16 | 2018 | 2161 | 1.090 |
Why?
|
| Glomerulonephritis | 17 | 2012 | 375 | 1.060 |
Why?
|
| Peptide Fragments | 22 | 2023 | 5124 | 0.980 |
Why?
|
| Vascular Diseases | 7 | 2022 | 1160 | 0.890 |
Why?
|
| T-Lymphocytes | 79 | 2023 | 10256 | 0.890 |
Why?
|
| Antibodies | 23 | 2022 | 2454 | 0.880 |
Why?
|
| Swine | 55 | 2024 | 5965 | 0.880 |
Why?
|
| Antibodies, Monoclonal | 76 | 2023 | 9300 | 0.880 |
Why?
|
| Swine, Miniature | 31 | 2018 | 969 | 0.870 |
Why?
|
| Animals, Genetically Modified | 12 | 2023 | 1563 | 0.780 |
Why?
|
| Complement System Proteins | 8 | 2013 | 803 | 0.780 |
Why?
|
| Acute Kidney Injury | 14 | 2023 | 1894 | 0.760 |
Why?
|
| Kidney Failure, Chronic | 17 | 2020 | 2499 | 0.750 |
Why?
|
| Papio | 21 | 2024 | 666 | 0.740 |
Why?
|
| HLA Antigens | 20 | 2023 | 1356 | 0.740 |
Why?
|
| Orbital Pseudotumor | 1 | 2020 | 42 | 0.740 |
Why?
|
| Complement C4 | 5 | 2007 | 255 | 0.730 |
Why?
|
| Animals | 256 | 2024 | 169600 | 0.720 |
Why?
|
| Fibrosis | 18 | 2023 | 2028 | 0.690 |
Why?
|
| Immunoglobulin G | 22 | 2023 | 4575 | 0.680 |
Why?
|
| Histocompatibility Antigens Class II | 13 | 2012 | 1469 | 0.680 |
Why?
|
| Forkhead Transcription Factors | 9 | 2020 | 1621 | 0.670 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 7 | 2010 | 355 | 0.670 |
Why?
|
| Lacrimal Apparatus | 1 | 2020 | 225 | 0.640 |
Why?
|
| Transplants | 1 | 2020 | 209 | 0.620 |
Why?
|
| Facial Transplantation | 1 | 2020 | 225 | 0.620 |
Why?
|
| Fabry Disease | 5 | 2019 | 92 | 0.620 |
Why?
|
| Antigen-Antibody Complex | 7 | 2015 | 530 | 0.620 |
Why?
|
| Tumor Virus Infections | 7 | 2020 | 448 | 0.610 |
Why?
|
| Transplantation Immunology | 9 | 2009 | 541 | 0.600 |
Why?
|
| Primates | 3 | 2023 | 547 | 0.600 |
Why?
|
| Lupus Nephritis | 5 | 2018 | 304 | 0.600 |
Why?
|
| Cyclosporine | 17 | 2007 | 785 | 0.590 |
Why?
|
| Endothelium | 9 | 2018 | 779 | 0.590 |
Why?
|
| Kidney Tubules, Proximal | 3 | 2017 | 409 | 0.580 |
Why?
|
| Tissue Donors | 14 | 2023 | 2234 | 0.580 |
Why?
|
| Skin Transplantation | 19 | 2019 | 1080 | 0.570 |
Why?
|
| Autoantibodies | 9 | 2017 | 2068 | 0.560 |
Why?
|
| Rosa | 1 | 2016 | 8 | 0.550 |
Why?
|
| Hepatitis C | 8 | 2011 | 1597 | 0.550 |
Why?
|
| Histocompatibility | 8 | 2018 | 323 | 0.550 |
Why?
|
| BK Virus | 5 | 2020 | 124 | 0.540 |
Why?
|
| Chronic Disease | 29 | 2019 | 9223 | 0.540 |
Why?
|
| Liver Transplantation | 13 | 2017 | 2137 | 0.540 |
Why?
|
| Endarteritis | 2 | 2010 | 5 | 0.530 |
Why?
|
| Galactosyltransferases | 5 | 2011 | 267 | 0.530 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 9431 | 0.510 |
Why?
|
| Hypersensitivity, Delayed | 17 | 2009 | 484 | 0.490 |
Why?
|
| Humans | 294 | 2024 | 752741 | 0.480 |
Why?
|
| Polyomavirus Infections | 6 | 2020 | 195 | 0.480 |
Why?
|
| Transplantation Conditioning | 19 | 2020 | 1595 | 0.480 |
Why?
|
| Thymus Gland | 20 | 2007 | 1276 | 0.470 |
Why?
|
| Acute Disease | 26 | 2024 | 7221 | 0.470 |
Why?
|
| T-Lymphocytes, Regulatory | 17 | 2023 | 3034 | 0.470 |
Why?
|
| Lung Transplantation | 8 | 2018 | 1139 | 0.460 |
Why?
|
| Immunity, Cellular | 18 | 2011 | 1610 | 0.460 |
Why?
|
| Thrombotic Microangiopathies | 2 | 2011 | 129 | 0.440 |
Why?
|
| Major Histocompatibility Complex | 15 | 2019 | 936 | 0.430 |
Why?
|
| Flow Cytometry | 37 | 2020 | 5974 | 0.430 |
Why?
|
| Mice, Inbred DBA | 6 | 2023 | 642 | 0.430 |
Why?
|
| Lymphocyte Depletion | 10 | 2014 | 607 | 0.420 |
Why?
|
| Autoimmune Diseases | 15 | 2010 | 2183 | 0.420 |
Why?
|
| Fibrin | 16 | 2017 | 508 | 0.410 |
Why?
|
| Capillaries | 9 | 2012 | 775 | 0.410 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 2 | 2012 | 304 | 0.400 |
Why?
|
| Chimerism | 7 | 2023 | 156 | 0.400 |
Why?
|
| Creatinine | 14 | 2021 | 1893 | 0.400 |
Why?
|
| Capillary Leak Syndrome | 1 | 2011 | 31 | 0.400 |
Why?
|
| Arteries | 4 | 2010 | 1123 | 0.390 |
Why?
|
| Biopsy, Needle | 7 | 2012 | 1642 | 0.390 |
Why?
|
| alpha-Galactosidase | 3 | 2019 | 58 | 0.390 |
Why?
|
| Proteinuria | 10 | 2023 | 654 | 0.380 |
Why?
|
| Wound Healing | 17 | 1996 | 2798 | 0.380 |
Why?
|
| Histocytochemistry | 4 | 2010 | 719 | 0.370 |
Why?
|
| Trihexosylceramides | 4 | 2019 | 32 | 0.370 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 15 | 2006 | 907 | 0.370 |
Why?
|
| Lymphangioma, Cystic | 1 | 2010 | 34 | 0.370 |
Why?
|
| Lymphangiectasis | 1 | 2010 | 20 | 0.370 |
Why?
|
| Cornea | 12 | 2004 | 1523 | 0.360 |
Why?
|
| Kidney Tubular Necrosis, Acute | 3 | 2006 | 66 | 0.360 |
Why?
|
| Immunohistochemistry | 15 | 2020 | 11395 | 0.350 |
Why?
|
| Fibrinogen | 13 | 1998 | 893 | 0.350 |
Why?
|
| Diagnosis, Differential | 13 | 2020 | 13042 | 0.340 |
Why?
|
| Polycythemia | 1 | 2010 | 126 | 0.340 |
Why?
|
| Mice | 86 | 2023 | 81766 | 0.340 |
Why?
|
| Receptors, Interleukin-2 | 8 | 1997 | 570 | 0.340 |
Why?
|
| Histocompatibility Testing | 18 | 2019 | 726 | 0.340 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2010 | 143 | 0.330 |
Why?
|
| 1-Deoxynojirimycin | 2 | 2019 | 18 | 0.330 |
Why?
|
| Tacrolimus | 5 | 2023 | 725 | 0.330 |
Why?
|
| Antigens, Surface | 16 | 1989 | 1664 | 0.330 |
Why?
|
| B-Lymphocytes | 14 | 2012 | 4716 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 37 | 2023 | 22009 | 0.320 |
Why?
|
| ABO Blood-Group System | 4 | 2007 | 380 | 0.320 |
Why?
|
| Fluorescent Antibody Technique | 32 | 2013 | 2499 | 0.310 |
Why?
|
| Polyomavirus | 3 | 2014 | 249 | 0.310 |
Why?
|
| Pathology | 3 | 2007 | 271 | 0.310 |
Why?
|
| Macrophages | 18 | 2020 | 5710 | 0.310 |
Why?
|
| Paraproteinemias | 1 | 2010 | 245 | 0.300 |
Why?
|
| RNA | 1 | 2018 | 2778 | 0.300 |
Why?
|
| T-Lymphocytes, Cytotoxic | 9 | 2009 | 1822 | 0.300 |
Why?
|
| Male | 148 | 2024 | 354311 | 0.300 |
Why?
|
| Coronary Artery Disease | 10 | 2015 | 6565 | 0.300 |
Why?
|
| Granuloma | 2 | 2014 | 321 | 0.290 |
Why?
|
| Blood Coagulation Factors | 4 | 2017 | 359 | 0.290 |
Why?
|
| Nephritis, Hereditary | 3 | 2023 | 91 | 0.290 |
Why?
|
| Thrombocytopenia | 2 | 2016 | 1186 | 0.290 |
Why?
|
| Heart-Lung Transplantation | 1 | 2007 | 67 | 0.290 |
Why?
|
| Disease Models, Animal | 25 | 2023 | 18174 | 0.290 |
Why?
|
| Postoperative Complications | 16 | 2020 | 15459 | 0.280 |
Why?
|
| Brain Death | 2 | 2022 | 348 | 0.280 |
Why?
|
| Receptors, Antigen, T-Cell | 12 | 2023 | 2555 | 0.280 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2007 | 89 | 0.280 |
Why?
|
| Histocompatibility Antigens Class I | 12 | 2003 | 1368 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 7 | 1996 | 1614 | 0.270 |
Why?
|
| Immunoenzyme Techniques | 15 | 2014 | 1798 | 0.270 |
Why?
|
| Complement Activation | 4 | 2013 | 452 | 0.270 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 7 | 1988 | 838 | 0.270 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2008 | 175 | 0.270 |
Why?
|
| Dehydration | 1 | 2007 | 232 | 0.270 |
Why?
|
| Arteritis | 4 | 2017 | 163 | 0.270 |
Why?
|
| Antilymphocyte Serum | 16 | 2015 | 482 | 0.260 |
Why?
|
| Guinea Pigs | 29 | 1990 | 1395 | 0.260 |
Why?
|
| Tunica Intima | 2 | 2007 | 464 | 0.260 |
Why?
|
| Skin | 22 | 2020 | 4393 | 0.260 |
Why?
|
| Hemolytic-Uremic Syndrome | 4 | 2019 | 109 | 0.250 |
Why?
|
| Basement Membrane | 15 | 2017 | 358 | 0.250 |
Why?
|
| Puerperal Disorders | 1 | 2008 | 293 | 0.250 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 495 | 0.250 |
Why?
|
| Formaldehyde | 2 | 2023 | 357 | 0.240 |
Why?
|
| Renal Insufficiency | 4 | 2022 | 813 | 0.240 |
Why?
|
| Endothelium, Lymphatic | 1 | 2004 | 63 | 0.240 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 1999 | 1160 | 0.230 |
Why?
|
| Interleukin-2 | 9 | 2023 | 1904 | 0.230 |
Why?
|
| Thrombosis | 5 | 2019 | 3035 | 0.230 |
Why?
|
| Cytotoxicity, Immunologic | 20 | 2013 | 1370 | 0.230 |
Why?
|
| DNA, Neoplasm | 6 | 1994 | 1753 | 0.220 |
Why?
|
| Prostatic Neoplasms | 3 | 2021 | 11211 | 0.220 |
Why?
|
| Pancreatitis | 2 | 2007 | 1102 | 0.220 |
Why?
|
| Mice, Inbred Strains | 12 | 2008 | 1830 | 0.220 |
Why?
|
| Dendritic Cells | 6 | 2020 | 2766 | 0.220 |
Why?
|
| CD4-Positive T-Lymphocytes | 15 | 2011 | 4403 | 0.210 |
Why?
|
| Basophils | 13 | 1987 | 398 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 19 | 2014 | 6417 | 0.210 |
Why?
|
| Collagen Type III | 2 | 2014 | 90 | 0.210 |
Why?
|
| Prognosis | 23 | 2019 | 29264 | 0.210 |
Why?
|
| Ibuprofen | 1 | 2003 | 236 | 0.210 |
Why?
|
| Lymphocyte Activation | 15 | 2008 | 5552 | 0.200 |
Why?
|
| Shiga Toxin 2 | 2 | 2019 | 21 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2019 | 3901 | 0.200 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2005 | 640 | 0.200 |
Why?
|
| Glomerular Basement Membrane | 2 | 2022 | 35 | 0.190 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2020 | 529 | 0.190 |
Why?
|
| Apoptosis | 12 | 2013 | 9657 | 0.190 |
Why?
|
| CD40 Ligand | 6 | 2023 | 527 | 0.190 |
Why?
|
| Middle Aged | 69 | 2021 | 216054 | 0.190 |
Why?
|
| Time Factors | 40 | 2018 | 40195 | 0.190 |
Why?
|
| Crohn Disease | 1 | 2014 | 2321 | 0.190 |
Why?
|
| Alternative Splicing | 5 | 2004 | 1118 | 0.190 |
Why?
|
| Female | 114 | 2024 | 385090 | 0.190 |
Why?
|
| Pancreas Transplantation | 3 | 2012 | 187 | 0.190 |
Why?
|
| Immunoglobulin Idiotypes | 5 | 1989 | 201 | 0.180 |
Why?
|
| Terminology as Topic | 3 | 2018 | 1547 | 0.180 |
Why?
|
| Whole-Body Irradiation | 13 | 2014 | 445 | 0.180 |
Why?
|
| Endothelium, Vascular | 8 | 2012 | 4459 | 0.180 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 3 | 2012 | 42 | 0.180 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2020 | 811 | 0.180 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20026 | 0.180 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2020 | 2191 | 0.180 |
Why?
|
| Interferon-gamma | 11 | 2009 | 3220 | 0.170 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 15657 | 0.170 |
Why?
|
| Lymphatic Vessels | 1 | 2004 | 355 | 0.170 |
Why?
|
| RNA, Messenger | 12 | 2023 | 13011 | 0.170 |
Why?
|
| Predictive Value of Tests | 11 | 2019 | 15164 | 0.170 |
Why?
|
| Antigens, Heterophile | 1 | 2019 | 71 | 0.170 |
Why?
|
| Bacteremia | 1 | 2006 | 961 | 0.170 |
Why?
|
| Thymectomy | 7 | 2003 | 193 | 0.170 |
Why?
|
| Antibodies, Anti-Idiotypic | 8 | 2002 | 352 | 0.170 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 1999 | 61 | 0.170 |
Why?
|
| Cytoskeletal Proteins | 3 | 2011 | 1362 | 0.170 |
Why?
|
| Immunocompromised Host | 4 | 2009 | 847 | 0.170 |
Why?
|
| DNA Fragmentation | 3 | 2002 | 243 | 0.170 |
Why?
|
| Necrosis | 6 | 2008 | 1641 | 0.170 |
Why?
|
| Chimera | 5 | 2014 | 484 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2002 | 585 | 0.160 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2019 | 80 | 0.160 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 428 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 381 | 0.160 |
Why?
|
| Mannose-Binding Lectin | 1 | 2019 | 150 | 0.160 |
Why?
|
| Microcirculation | 5 | 2008 | 1307 | 0.160 |
Why?
|
| Reperfusion Injury | 4 | 2009 | 1027 | 0.160 |
Why?
|
| Adult | 67 | 2021 | 216658 | 0.160 |
Why?
|
| Lymphocyte Culture Test, Mixed | 12 | 2020 | 519 | 0.160 |
Why?
|
| Non-Fibrillar Collagens | 2 | 1991 | 24 | 0.160 |
Why?
|
| Nephrotic Syndrome | 3 | 2016 | 400 | 0.160 |
Why?
|
| Blood Group Incompatibility | 2 | 2011 | 141 | 0.160 |
Why?
|
| Capillary Permeability | 5 | 2009 | 805 | 0.160 |
Why?
|
| Immunity, Humoral | 3 | 2013 | 596 | 0.160 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2018 | 75 | 0.160 |
Why?
|
| Blood Platelets | 4 | 2019 | 2526 | 0.150 |
Why?
|
| Edema | 5 | 2010 | 800 | 0.150 |
Why?
|
| Microscopy, Electron | 13 | 2004 | 2644 | 0.150 |
Why?
|
| Immune Complex Diseases | 3 | 2006 | 53 | 0.150 |
Why?
|
| Renal Artery | 2 | 1999 | 390 | 0.150 |
Why?
|
| Tissue and Organ Procurement | 2 | 2023 | 887 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2287 | 0.150 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2017 | 267 | 0.150 |
Why?
|
| Lung | 6 | 2022 | 9990 | 0.150 |
Why?
|
| Prostatic Hyperplasia | 1 | 2021 | 527 | 0.150 |
Why?
|
| Atrophy | 3 | 2012 | 1600 | 0.150 |
Why?
|
| Eye Injuries | 2 | 2004 | 244 | 0.150 |
Why?
|
| Lymphocytes | 12 | 2006 | 2617 | 0.150 |
Why?
|
| Mucous Membrane | 1 | 2020 | 673 | 0.150 |
Why?
|
| Staphylococcal Infections | 1 | 2006 | 1405 | 0.150 |
Why?
|
| Pathology, Molecular | 1 | 2020 | 331 | 0.140 |
Why?
|
| Histocompatibility Antigens | 2 | 2015 | 472 | 0.140 |
Why?
|
| Interferons | 1 | 2020 | 720 | 0.140 |
Why?
|
| Corneal Stroma | 2 | 1996 | 174 | 0.140 |
Why?
|
| Receptors, Erythropoietin | 1 | 2017 | 147 | 0.140 |
Why?
|
| Receptor Cross-Talk | 1 | 2017 | 118 | 0.140 |
Why?
|
| Hemopexin | 1 | 2016 | 33 | 0.140 |
Why?
|
| Penile Neoplasms | 1 | 2018 | 161 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3605 | 0.140 |
Why?
|
| Immunologic Memory | 4 | 2015 | 1360 | 0.140 |
Why?
|
| Antibodies, Neoplasm | 3 | 2009 | 286 | 0.140 |
Why?
|
| Aged | 37 | 2021 | 165629 | 0.140 |
Why?
|
| Urologic Neoplasms | 1 | 2020 | 320 | 0.140 |
Why?
|
| Anti-Glomerular Basement Membrane Disease | 1 | 2016 | 42 | 0.140 |
Why?
|
| Steroids | 4 | 2023 | 940 | 0.140 |
Why?
|
| Cyclosporins | 8 | 1991 | 220 | 0.140 |
Why?
|
| Fish Oils | 4 | 1994 | 474 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 11 | 2018 | 4549 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 8 | 2015 | 2702 | 0.130 |
Why?
|
| Proliferating Cell Nuclear Antigen | 4 | 2002 | 284 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 35798 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 6 | 2019 | 1843 | 0.130 |
Why?
|
| Ischemia | 5 | 2018 | 1924 | 0.130 |
Why?
|
| Leukocytes | 4 | 2020 | 2056 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2009 | 1834 | 0.130 |
Why?
|
| Hypertension, Renovascular | 1 | 1996 | 130 | 0.130 |
Why?
|
| Epithelium | 10 | 1996 | 1682 | 0.130 |
Why?
|
| Kidney Neoplasms | 7 | 2020 | 4280 | 0.130 |
Why?
|
| Haptoglobins | 1 | 2016 | 167 | 0.130 |
Why?
|
| Immunity | 2 | 2020 | 1007 | 0.130 |
Why?
|
| Virus Diseases | 3 | 2001 | 722 | 0.130 |
Why?
|
| Mycophenolic Acid | 3 | 2023 | 335 | 0.130 |
Why?
|
| Plasma Exchange | 2 | 2010 | 164 | 0.130 |
Why?
|
| Endothelial Cells | 5 | 2023 | 3518 | 0.130 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 1995 | 379 | 0.130 |
Why?
|
| Follow-Up Studies | 15 | 2019 | 39223 | 0.120 |
Why?
|
| In Situ Hybridization | 4 | 2020 | 1944 | 0.120 |
Why?
|
| Hydroxyurea | 1 | 2016 | 288 | 0.120 |
Why?
|
| Inflammation | 10 | 2023 | 10751 | 0.120 |
Why?
|
| Eye Injuries, Penetrating | 1 | 1996 | 114 | 0.120 |
Why?
|
| Leukocyte Count | 11 | 2011 | 1604 | 0.120 |
Why?
|
| Polycythemia Vera | 1 | 2016 | 164 | 0.120 |
Why?
|
| Cryoglobulins | 2 | 2008 | 58 | 0.120 |
Why?
|
| Desensitization, Immunologic | 1 | 2019 | 485 | 0.120 |
Why?
|
| S Phase | 2 | 1994 | 424 | 0.120 |
Why?
|
| Preoperative Care | 3 | 2020 | 2258 | 0.120 |
Why?
|
| Hematologic Tests | 2 | 2006 | 238 | 0.120 |
Why?
|
| Chemokine CXCL9 | 2 | 2024 | 137 | 0.110 |
Why?
|
| Consensus | 2 | 2020 | 3023 | 0.110 |
Why?
|
| Dietary Fats | 3 | 1993 | 2012 | 0.110 |
Why?
|
| Complement C3 | 5 | 2012 | 463 | 0.110 |
Why?
|
| Immune Sera | 8 | 1983 | 642 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 2 | 2019 | 2654 | 0.110 |
Why?
|
| Arteriosclerosis | 1 | 1997 | 1090 | 0.110 |
Why?
|
| Coronary Vessels | 5 | 2015 | 3147 | 0.110 |
Why?
|
| Quality Assurance, Health Care | 2 | 2014 | 2215 | 0.110 |
Why?
|
| Research Report | 4 | 2018 | 354 | 0.110 |
Why?
|
| Retrospective Studies | 19 | 2023 | 78758 | 0.110 |
Why?
|
| Prostate | 1 | 2021 | 1794 | 0.110 |
Why?
|
| Rabbits | 17 | 1991 | 4910 | 0.110 |
Why?
|
| Disease Progression | 7 | 2019 | 13364 | 0.110 |
Why?
|
| Blood Chemical Analysis | 2 | 2006 | 440 | 0.110 |
Why?
|
| Receptors, Immunologic | 4 | 1988 | 1436 | 0.110 |
Why?
|
| Afibrinogenemia | 2 | 1984 | 18 | 0.110 |
Why?
|
| Corneal Ulcer | 2 | 1991 | 167 | 0.100 |
Why?
|
| Autopsy | 2 | 2020 | 1024 | 0.100 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2010 | 647 | 0.100 |
Why?
|
| Lung Diseases | 3 | 2015 | 1890 | 0.100 |
Why?
|
| Pneumonia | 2 | 2022 | 2154 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 1708 | 0.100 |
Why?
|
| Heart | 3 | 2019 | 4458 | 0.100 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2012 | 193 | 0.100 |
Why?
|
| Microfilament Proteins | 2 | 2014 | 1152 | 0.100 |
Why?
|
| Azo Compounds | 2 | 2010 | 113 | 0.100 |
Why?
|
| Models, Animal | 7 | 2015 | 2175 | 0.100 |
Why?
|
| Isoantigens | 2 | 2011 | 565 | 0.100 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2005 | 1119 | 0.100 |
Why?
|
| Minor Histocompatibility Antigens | 2 | 2011 | 298 | 0.100 |
Why?
|
| Muromonab-CD3 | 1 | 1991 | 104 | 0.100 |
Why?
|
| Immunoglobulin M | 7 | 2008 | 1537 | 0.100 |
Why?
|
| Antigens, CD | 4 | 2011 | 4028 | 0.100 |
Why?
|
| Prostate-Specific Antigen | 1 | 2021 | 2517 | 0.100 |
Why?
|
| Methyl Green | 1 | 2010 | 6 | 0.100 |
Why?
|
| Periodic Acid-Schiff Reaction | 1 | 2010 | 15 | 0.100 |
Why?
|
| Adolescent | 26 | 2021 | 86713 | 0.100 |
Why?
|
| Transplantation | 1 | 2012 | 210 | 0.100 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2010 | 71 | 0.100 |
Why?
|
| Diarrhea | 1 | 2018 | 1351 | 0.100 |
Why?
|
| Haplorhini | 3 | 2008 | 549 | 0.090 |
Why?
|
| Canada | 3 | 2023 | 2081 | 0.090 |
Why?
|
| Papillomavirus Infections | 2 | 2001 | 1595 | 0.090 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 1445 | 0.090 |
Why?
|
| Plasma Cells | 3 | 2011 | 596 | 0.090 |
Why?
|
| Hemorrhage | 2 | 2016 | 3530 | 0.090 |
Why?
|
| Collagen | 5 | 1993 | 2689 | 0.090 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 1994 | 327 | 0.090 |
Why?
|
| Sus scrofa | 2 | 2017 | 438 | 0.090 |
Why?
|
| H-2 Antigens | 4 | 1986 | 364 | 0.090 |
Why?
|
| Membrane Glycoproteins | 4 | 2009 | 3761 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 4 | 2023 | 5469 | 0.090 |
Why?
|
| Young Adult | 12 | 2021 | 57267 | 0.090 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.090 |
Why?
|
| Dose-Response Relationship, Immunologic | 5 | 1998 | 374 | 0.090 |
Why?
|
| Living Donors | 3 | 2023 | 607 | 0.090 |
Why?
|
| Delayed Graft Function | 1 | 2009 | 47 | 0.090 |
Why?
|
| Endocytosis | 2 | 2011 | 987 | 0.090 |
Why?
|
| Arenaviridae Infections | 1 | 2009 | 51 | 0.090 |
Why?
|
| Mycosis Fungoides | 1 | 1991 | 164 | 0.090 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2001 | 189 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2020 | 2267 | 0.090 |
Why?
|
| Stem Cell Factor | 1 | 2010 | 218 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 2 | 2020 | 156 | 0.090 |
Why?
|
| Phenotype | 9 | 2017 | 16484 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 4 | 2019 | 2160 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2011 | 431 | 0.090 |
Why?
|
| Telepathology | 1 | 2009 | 77 | 0.080 |
Why?
|
| Cryoglobulinemia | 2 | 2008 | 87 | 0.080 |
Why?
|
| Adoptive Transfer | 5 | 2020 | 842 | 0.080 |
Why?
|
| Coronary Disease | 2 | 2009 | 6083 | 0.080 |
Why?
|
| Venous Thrombosis | 1 | 1999 | 1295 | 0.080 |
Why?
|
| Papio hamadryas | 1 | 2008 | 31 | 0.080 |
Why?
|
| HLA-DR Antigens | 3 | 1997 | 644 | 0.080 |
Why?
|
| Lymphocyte Transfusion | 4 | 1999 | 236 | 0.080 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2010 | 227 | 0.080 |
Why?
|
| Sirolimus | 2 | 2009 | 1568 | 0.080 |
Why?
|
| Kidney Cortex | 3 | 1997 | 184 | 0.080 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2009 | 168 | 0.080 |
Why?
|
| Monocytes | 6 | 1989 | 2602 | 0.080 |
Why?
|
| Hydronephrosis | 1 | 2010 | 274 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2014 | 3885 | 0.080 |
Why?
|
| Antibodies, Heterophile | 5 | 1999 | 127 | 0.080 |
Why?
|
| Rats | 19 | 2004 | 24248 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 1997 | 2955 | 0.080 |
Why?
|
| Confusion | 1 | 2010 | 280 | 0.080 |
Why?
|
| Eye Burns | 2 | 2004 | 103 | 0.080 |
Why?
|
| Spleen | 3 | 2011 | 2369 | 0.080 |
Why?
|
| Virus Integration | 2 | 2020 | 300 | 0.080 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2010 | 471 | 0.080 |
Why?
|
| Thromboembolism | 4 | 2019 | 996 | 0.080 |
Why?
|
| Fibroblasts | 4 | 2002 | 4160 | 0.080 |
Why?
|
| Hiccup | 1 | 2007 | 9 | 0.080 |
Why?
|
| Myocardium | 6 | 2008 | 4719 | 0.080 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 1976 | 0.080 |
Why?
|
| Erythrocytes | 4 | 2016 | 2463 | 0.080 |
Why?
|
| Immunotherapy | 3 | 2021 | 4526 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 1997 | 1913 | 0.080 |
Why?
|
| Skin Tests | 7 | 1987 | 621 | 0.080 |
Why?
|
| Burns, Chemical | 2 | 2004 | 159 | 0.080 |
Why?
|
| Burns | 1 | 2019 | 1839 | 0.080 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2008 | 72 | 0.080 |
Why?
|
| Intestines | 3 | 2010 | 1924 | 0.080 |
Why?
|
| Autoantigens | 3 | 2010 | 901 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2012 | 609 | 0.080 |
Why?
|
| Antigens | 10 | 1984 | 1466 | 0.080 |
Why?
|
| Lymph Nodes | 8 | 2002 | 3503 | 0.070 |
Why?
|
| Membrane Proteins | 5 | 2023 | 7941 | 0.070 |
Why?
|
| Transgenes | 2 | 2023 | 1012 | 0.070 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2008 | 111 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2012 | 714 | 0.070 |
Why?
|
| Cytomegalovirus | 2 | 2008 | 734 | 0.070 |
Why?
|
| Anabolic Agents | 1 | 2009 | 246 | 0.070 |
Why?
|
| Immunoconjugates | 1 | 2014 | 919 | 0.070 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 1994 | 1362 | 0.070 |
Why?
|
| Streptozocin | 2 | 2005 | 196 | 0.070 |
Why?
|
| Electrophoresis, Agar Gel | 3 | 2001 | 214 | 0.070 |
Why?
|
| Lymphokines | 2 | 1990 | 945 | 0.070 |
Why?
|
| Extracellular Matrix | 5 | 2002 | 1747 | 0.070 |
Why?
|
| Pathology, Clinical | 2 | 2009 | 375 | 0.070 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14596 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 240 | 0.070 |
Why?
|
| Microscopy | 1 | 2012 | 903 | 0.070 |
Why?
|
| Cells, Cultured | 14 | 2015 | 19270 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 5 | 2014 | 6169 | 0.070 |
Why?
|
| Melanoma | 3 | 2022 | 5547 | 0.070 |
Why?
|
| Virus Activation | 1 | 2008 | 319 | 0.070 |
Why?
|
| Antibody Specificity | 8 | 2001 | 1089 | 0.070 |
Why?
|
| Wounds, Penetrating | 1 | 1989 | 307 | 0.070 |
Why?
|
| Podocytes | 1 | 2010 | 406 | 0.070 |
Why?
|
| Interferon Type I | 2 | 1990 | 550 | 0.070 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2006 | 87 | 0.070 |
Why?
|
| Receptors, Virus | 1 | 2009 | 643 | 0.070 |
Why?
|
| Central Nervous System Diseases | 1 | 2010 | 520 | 0.070 |
Why?
|
| Kidney Function Tests | 3 | 2015 | 676 | 0.070 |
Why?
|
| Transplantation, Autologous | 4 | 2015 | 2125 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2022 | 4420 | 0.070 |
Why?
|
| Splenectomy | 6 | 2010 | 395 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2023 | 647 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 7 | 2008 | 817 | 0.070 |
Why?
|
| Glomerular Mesangium | 2 | 2002 | 107 | 0.070 |
Why?
|
| Carrier Proteins | 3 | 1991 | 5006 | 0.070 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2087 | 0.070 |
Why?
|
| Mice, Inbred NZB | 3 | 1993 | 57 | 0.070 |
Why?
|
| Ploidies | 3 | 1994 | 282 | 0.060 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 1987 | 226 | 0.060 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2009 | 575 | 0.060 |
Why?
|
| Fatal Outcome | 2 | 2009 | 1859 | 0.060 |
Why?
|
| Urinalysis | 1 | 2007 | 368 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 740 | 0.060 |
Why?
|
| Mice, Inbred C3H | 2 | 2020 | 966 | 0.060 |
Why?
|
| Treatment Outcome | 9 | 2019 | 64017 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2011 | 2112 | 0.060 |
Why?
|
| Laminin | 4 | 1993 | 420 | 0.060 |
Why?
|
| Paraffin Embedding | 3 | 2015 | 304 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 2606 | 0.060 |
Why?
|
| Treatment Failure | 2 | 2020 | 2642 | 0.060 |
Why?
|
| Clinical Trials as Topic | 7 | 2012 | 7970 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 1991 | 4455 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 14761 | 0.060 |
Why?
|
| Disaccharides | 2 | 2003 | 173 | 0.060 |
Why?
|
| Epitopes | 7 | 2003 | 2584 | 0.060 |
Why?
|
| Observer Variation | 3 | 2014 | 2622 | 0.060 |
Why?
|
| Adenoma | 2 | 2002 | 2182 | 0.060 |
Why?
|
| Risk | 5 | 2021 | 9683 | 0.060 |
Why?
|
| Mice, Transgenic | 6 | 2019 | 9743 | 0.060 |
Why?
|
| Renal Circulation | 3 | 2007 | 332 | 0.060 |
Why?
|
| Radiography | 3 | 2010 | 7047 | 0.060 |
Why?
|
| Vomiting | 1 | 2007 | 637 | 0.060 |
Why?
|
| Neointima | 2 | 2015 | 135 | 0.060 |
Why?
|
| Cell Separation | 8 | 2020 | 1751 | 0.060 |
Why?
|
| Nephrosis | 1 | 2003 | 45 | 0.060 |
Why?
|
| Aged, 80 and over | 9 | 2021 | 58361 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2010 | 748 | 0.060 |
Why?
|
| Pulmonary Alveoli | 4 | 2022 | 671 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1670 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 1999 | 18050 | 0.060 |
Why?
|
| Ultrasonography | 2 | 2010 | 6037 | 0.060 |
Why?
|
| Neutropenia | 1 | 2008 | 893 | 0.060 |
Why?
|
| Cell Differentiation | 7 | 2023 | 11553 | 0.060 |
Why?
|
| Proteins | 2 | 1997 | 6093 | 0.060 |
Why?
|
| Acetaldehyde | 1 | 2022 | 39 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2023 | 120 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2022 | 32 | 0.050 |
Why?
|
| Cyclophosphamide | 2 | 2008 | 2252 | 0.050 |
Why?
|
| Neutrophils | 9 | 2012 | 3729 | 0.050 |
Why?
|
| Nephritis | 1 | 2003 | 157 | 0.050 |
Why?
|
| Schools, Medical | 1 | 1989 | 882 | 0.050 |
Why?
|
| beta Catenin | 3 | 2014 | 1066 | 0.050 |
Why?
|
| Bone Marrow | 2 | 2011 | 2945 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 697 | 0.050 |
Why?
|
| Skin Physiological Phenomena | 1 | 1983 | 181 | 0.050 |
Why?
|
| Immunologic Techniques | 2 | 1999 | 218 | 0.050 |
Why?
|
| RNA, Nuclear | 1 | 2002 | 30 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2011 | 2449 | 0.050 |
Why?
|
| Coronary Circulation | 2 | 2007 | 1592 | 0.050 |
Why?
|
| PUVA Therapy | 1 | 1982 | 99 | 0.050 |
Why?
|
| Siblings | 1 | 2006 | 850 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3136 | 0.050 |
Why?
|
| Mesencephalon | 1 | 1984 | 330 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3246 | 0.050 |
Why?
|
| Cell Division | 5 | 1999 | 4549 | 0.050 |
Why?
|
| Vasculitis | 1 | 2006 | 520 | 0.050 |
Why?
|
| Up-Regulation | 4 | 2009 | 4194 | 0.050 |
Why?
|
| Trisaccharides | 1 | 2001 | 50 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 3334 | 0.050 |
Why?
|
| Donor Selection | 1 | 2023 | 201 | 0.050 |
Why?
|
| Cisplatin | 2 | 2006 | 1664 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 2881 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 1989 | 976 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2011 | 1887 | 0.050 |
Why?
|
| Aldehydes | 1 | 2022 | 168 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4041 | 0.050 |
Why?
|
| Glycerol | 1 | 2022 | 280 | 0.050 |
Why?
|
| Neoplasms | 5 | 2021 | 21976 | 0.050 |
Why?
|
| Amyloid | 1 | 2006 | 805 | 0.050 |
Why?
|
| Blood Vessels | 2 | 2005 | 1127 | 0.050 |
Why?
|
| Anemia | 1 | 2010 | 1505 | 0.050 |
Why?
|
| Cellulose | 1 | 2001 | 120 | 0.050 |
Why?
|
| Free Radicals | 1 | 2001 | 237 | 0.050 |
Why?
|
| Mice, Nude | 4 | 2012 | 3668 | 0.050 |
Why?
|
| Endpoint Determination | 1 | 2004 | 599 | 0.050 |
Why?
|
| Patient Care | 1 | 2007 | 638 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2007 | 1062 | 0.050 |
Why?
|
| Thrombophilia | 1 | 2004 | 318 | 0.050 |
Why?
|
| Amyloidosis | 2 | 2006 | 808 | 0.050 |
Why?
|
| Lithium | 1 | 1984 | 605 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2011 | 3489 | 0.050 |
Why?
|
| Corneal Diseases | 1 | 1987 | 642 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 1994 | 2302 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2008 | 1062 | 0.050 |
Why?
|
| Drug Therapy, Combination | 4 | 2018 | 6493 | 0.050 |
Why?
|
| Islets of Langerhans | 2 | 2010 | 1351 | 0.050 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2004 | 428 | 0.050 |
Why?
|
| Oximes | 1 | 2022 | 309 | 0.050 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2011 | 2755 | 0.050 |
Why?
|
| Survival Rate | 5 | 2019 | 12802 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 157 | 0.050 |
Why?
|
| Base Sequence | 4 | 1995 | 12769 | 0.050 |
Why?
|
| Cell Movement | 7 | 2006 | 5222 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2020 | 172 | 0.040 |
Why?
|
| Genes, RAG-1 | 1 | 1999 | 68 | 0.040 |
Why?
|
| Gene Expression | 5 | 2014 | 7771 | 0.040 |
Why?
|
| Horses | 3 | 2015 | 305 | 0.040 |
Why?
|
| Genes, MHC Class II | 3 | 1985 | 456 | 0.040 |
Why?
|
| Shiga Toxin | 1 | 2019 | 33 | 0.040 |
Why?
|
| Temporal Bone | 1 | 2004 | 675 | 0.040 |
Why?
|
| Dyspnea | 1 | 2008 | 1316 | 0.040 |
Why?
|
| DNA Primers | 2 | 1994 | 2880 | 0.040 |
Why?
|
| Alleles | 2 | 2021 | 6954 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2002 | 283 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 2001 | 377 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 1979 | 162 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 3766 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 5 | 1997 | 987 | 0.040 |
Why?
|
| Risk Factors | 7 | 2019 | 73094 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 1999 | 139 | 0.040 |
Why?
|
| Immunoglobulin Isotypes | 2 | 1998 | 156 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2022 | 383 | 0.040 |
Why?
|
| Cell Transformation, Viral | 2 | 1984 | 566 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2011 | 3761 | 0.040 |
Why?
|
| Complement Inactivating Agents | 1 | 2019 | 50 | 0.040 |
Why?
|
| Ureteral Diseases | 1 | 1999 | 61 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 2 | 1992 | 363 | 0.040 |
Why?
|
| Species Specificity | 5 | 2006 | 2483 | 0.040 |
Why?
|
| GATA3 Transcription Factor | 1 | 2019 | 159 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 310 | 0.040 |
Why?
|
| Cattle | 3 | 1995 | 3926 | 0.040 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 1991 | 481 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2003 | 2030 | 0.040 |
Why?
|
| Sodium Hydroxide | 2 | 2004 | 44 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 3 | 2002 | 1054 | 0.040 |
Why?
|
| Drug Synergism | 4 | 2005 | 1768 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2023 | 8413 | 0.040 |
Why?
|
| Renal Dialysis | 3 | 2002 | 1749 | 0.040 |
Why?
|
| Cytokines | 5 | 2018 | 7400 | 0.040 |
Why?
|
| Viremia | 2 | 1997 | 739 | 0.040 |
Why?
|
| Mast Cells | 3 | 1974 | 1555 | 0.040 |
Why?
|
| Skin Neoplasms | 4 | 1993 | 5751 | 0.040 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2004 | 777 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2001 | 671 | 0.040 |
Why?
|
| Antigens, Neoplasm | 3 | 1983 | 2002 | 0.040 |
Why?
|
| Multiple Myeloma | 2 | 2006 | 5076 | 0.040 |
Why?
|
| Cochlea | 1 | 2004 | 839 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 1998 | 171 | 0.040 |
Why?
|
| Receptors, Fibronectin | 2 | 1988 | 39 | 0.040 |
Why?
|
| Enteritis | 1 | 1999 | 167 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 2080 | 0.040 |
Why?
|
| Epithelial Cells | 4 | 2020 | 3757 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2018 | 1998 | 0.040 |
Why?
|
| Administration, Topical | 2 | 1991 | 691 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12250 | 0.040 |
Why?
|
| Arterioles | 1 | 1998 | 253 | 0.040 |
Why?
|
| Dermatitis, Contact | 3 | 1977 | 129 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 565 | 0.040 |
Why?
|
| International Cooperation | 2 | 1994 | 1439 | 0.040 |
Why?
|
| Poly(A)-Binding Proteins | 1 | 1997 | 36 | 0.040 |
Why?
|
| Microvilli | 1 | 2017 | 241 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 1999 | 389 | 0.040 |
Why?
|
| Ovarian Neoplasms | 5 | 1992 | 4872 | 0.040 |
Why?
|
| Myocardial Ischemia | 1 | 2008 | 2152 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 1989 | 2322 | 0.040 |
Why?
|
| Blood Coagulation | 4 | 2001 | 1143 | 0.040 |
Why?
|
| Graft vs Host Reaction | 1 | 1997 | 104 | 0.040 |
Why?
|
| Chemokines | 1 | 2001 | 975 | 0.040 |
Why?
|
| Cross Reactions | 2 | 2012 | 842 | 0.040 |
Why?
|
| Pyridones | 1 | 2022 | 738 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2023 | 1050 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 8971 | 0.040 |
Why?
|
| Guanidines | 4 | 1999 | 196 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 1993 | 3127 | 0.040 |
Why?
|
| Bioethics | 1 | 1998 | 116 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2019 | 53863 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2012 | 23512 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2020 | 676 | 0.040 |
Why?
|
| Organ Culture Techniques | 2 | 1989 | 808 | 0.040 |
Why?
|
| Quality of Life | 1 | 2018 | 13044 | 0.030 |
Why?
|
| Immunization, Passive | 6 | 1987 | 621 | 0.030 |
Why?
|
| Reference Values | 2 | 1999 | 4994 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2001 | 765 | 0.030 |
Why?
|
| Photorefractive Keratectomy | 1 | 1996 | 38 | 0.030 |
Why?
|
| Endocarditis | 1 | 2000 | 357 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2007 | 1554 | 0.030 |
Why?
|
| Curriculum | 1 | 1989 | 3633 | 0.030 |
Why?
|
| Growth Substances | 2 | 1989 | 783 | 0.030 |
Why?
|
| Photochemotherapy | 1 | 1982 | 805 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 2 | 1993 | 594 | 0.030 |
Why?
|
| Gene Expression Regulation | 4 | 2009 | 12054 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2730 | 0.030 |
Why?
|
| Lasers, Excimer | 1 | 1996 | 72 | 0.030 |
Why?
|
| RNA, Viral | 2 | 2002 | 2908 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 463 | 0.030 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 533 | 0.030 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1995 | 67 | 0.030 |
Why?
|
| Isomerism | 1 | 1995 | 197 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 1995 | 158 | 0.030 |
Why?
|
| Lymphoid Tissue | 2 | 1995 | 457 | 0.030 |
Why?
|
| Receptors, Fc | 2 | 1989 | 540 | 0.030 |
Why?
|
| Imidazoles | 1 | 2022 | 1201 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2013 | 21904 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3511 | 0.030 |
Why?
|
| Genotype | 2 | 2020 | 12970 | 0.030 |
Why?
|
| Child, Preschool | 5 | 2013 | 41390 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 427 | 0.030 |
Why?
|
| Clone Cells | 5 | 1990 | 1692 | 0.030 |
Why?
|
| Hypertension | 2 | 2007 | 8614 | 0.030 |
Why?
|
| Injections, Subcutaneous | 2 | 2015 | 680 | 0.030 |
Why?
|
| Fetus | 1 | 1983 | 1889 | 0.030 |
Why?
|
| Echocardiography | 1 | 2008 | 5117 | 0.030 |
Why?
|
| Immunoglobulin A | 1 | 1978 | 996 | 0.030 |
Why?
|
| Reperfusion | 1 | 1996 | 285 | 0.030 |
Why?
|
| Oxygen | 1 | 1986 | 4208 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2011 | 1875 | 0.030 |
Why?
|
| Culture Media | 2 | 1990 | 908 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 674 | 0.030 |
Why?
|
| Alberta | 1 | 2014 | 62 | 0.030 |
Why?
|
| Shock, Hemorrhagic | 1 | 2016 | 222 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2002 | 1495 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 182 | 0.030 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 152 | 0.030 |
Why?
|
| Phagocytosis | 3 | 2011 | 1555 | 0.030 |
Why?
|
| Endothelium, Corneal | 1 | 1996 | 197 | 0.030 |
Why?
|
| Psoriasis | 1 | 1982 | 913 | 0.030 |
Why?
|
| Cell Line | 9 | 2009 | 16004 | 0.030 |
Why?
|
| Immunogenetics | 1 | 1994 | 65 | 0.030 |
Why?
|
| Tissue Distribution | 3 | 1990 | 2335 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2004 | 6458 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2019 | 1205 | 0.030 |
Why?
|
| Aneuploidy | 3 | 1992 | 540 | 0.030 |
Why?
|
| Incidence | 4 | 2004 | 21146 | 0.030 |
Why?
|
| Cell Survival | 2 | 2017 | 5860 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1997 | 566 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2015 | 339 | 0.030 |
Why?
|
| Arthus Reaction | 1 | 1973 | 14 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1996 | 709 | 0.030 |
Why?
|
| Adenocarcinoma | 7 | 1983 | 6387 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2015 | 227 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1993 | 74 | 0.030 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1997 | 547 | 0.030 |
Why?
|
| Autoimmunity | 2 | 2012 | 1374 | 0.030 |
Why?
|
| Internationality | 1 | 2019 | 999 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2001 | 6352 | 0.030 |
Why?
|
| Antibodies, Bispecific | 1 | 1995 | 175 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2009 | 4290 | 0.030 |
Why?
|
| Prednisone | 2 | 1995 | 1585 | 0.030 |
Why?
|
| Research Design | 2 | 2012 | 6118 | 0.030 |
Why?
|
| Mutation | 4 | 2022 | 29981 | 0.030 |
Why?
|
| Monitoring, Immunologic | 2 | 2009 | 99 | 0.030 |
Why?
|
| Fats | 1 | 1993 | 103 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 2927 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2018 | 1063 | 0.030 |
Why?
|
| Leukemia, Lymphoid | 1 | 1973 | 315 | 0.030 |
Why?
|
| Complement C1q | 1 | 2013 | 90 | 0.030 |
Why?
|
| Rats, Inbred Strains | 3 | 1989 | 2182 | 0.030 |
Why?
|
| Venae Cavae | 1 | 1972 | 41 | 0.030 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1973 | 119 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3198 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2021 | 1908 | 0.030 |
Why?
|
| Cell Communication | 1 | 2020 | 1639 | 0.030 |
Why?
|
| Binding, Competitive | 2 | 1993 | 1156 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 110 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1999 | 2228 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2021 | 1572 | 0.030 |
Why?
|
| Omentum | 2 | 2003 | 171 | 0.030 |
Why?
|
| Complement C5a | 1 | 2012 | 107 | 0.030 |
Why?
|
| Injections, Intravenous | 3 | 2012 | 1420 | 0.030 |
Why?
|
| Phalloidine | 1 | 2011 | 21 | 0.030 |
Why?
|
| Binding Sites, Antibody | 3 | 1994 | 349 | 0.030 |
Why?
|
| Paraffin | 1 | 1991 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 2042 | 0.030 |
Why?
|
| Introns | 1 | 2014 | 988 | 0.030 |
Why?
|
| Cell Membrane Structures | 1 | 2011 | 27 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 2561 | 0.030 |
Why?
|
| Granulosa Cell Tumor | 1 | 1992 | 71 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2005 | 0.020 |
Why?
|
| Viral Load | 1 | 2020 | 3325 | 0.020 |
Why?
|
| Resuscitation | 1 | 2016 | 662 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2011 | 222 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 1977 | 902 | 0.020 |
Why?
|
| H-Y Antigen | 1 | 2011 | 44 | 0.020 |
Why?
|
| Pemphigoid, Bullous | 2 | 1984 | 113 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2011 | 98 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 1861 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2003 | 3002 | 0.020 |
Why?
|
| Immunoglobulins | 4 | 2004 | 881 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2016 | 1145 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2011 | 159 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1991 | 200 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1995 | 1104 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2019 | 0.020 |
Why?
|
| Factor VIII | 2 | 1984 | 356 | 0.020 |
Why?
|
| Cell Count | 3 | 2006 | 1856 | 0.020 |
Why?
|
| Maleimides | 1 | 2011 | 111 | 0.020 |
Why?
|
| Cell Proliferation | 3 | 2012 | 10508 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2012 | 10914 | 0.020 |
Why?
|
| Azathioprine | 2 | 1987 | 353 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 13678 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1990 | 113 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 383 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17635 | 0.020 |
Why?
|
| Pulmonary Fibrosis | 2 | 1986 | 530 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2003 | 3012 | 0.020 |
Why?
|
| Leukapheresis | 1 | 2010 | 133 | 0.020 |
Why?
|
| Antigens, CD7 | 1 | 1989 | 21 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 1977 | 1242 | 0.020 |
Why?
|
| Antigens, Differentiation | 2 | 1989 | 925 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2002 | 2957 | 0.020 |
Why?
|
| Ancrod | 1 | 1989 | 7 | 0.020 |
Why?
|
| Kinetics | 2 | 1990 | 6482 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 1708 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2011 | 8414 | 0.020 |
Why?
|
| Models, Immunological | 1 | 2012 | 523 | 0.020 |
Why?
|
| Gelatin | 2 | 1990 | 232 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 670 | 0.020 |
Why?
|
| ROC Curve | 1 | 2017 | 3558 | 0.020 |
Why?
|
| Peroxidase | 3 | 1999 | 609 | 0.020 |
Why?
|
| Immunoassay | 1 | 2013 | 749 | 0.020 |
Why?
|
| Lymphocytosis | 1 | 1990 | 122 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 15657 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 1992 | 973 | 0.020 |
Why?
|
| Autoradiography | 2 | 1984 | 745 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 1990 | 547 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2011 | 6624 | 0.020 |
Why?
|
| Mice, SCID | 1 | 1994 | 2693 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 1989 | 625 | 0.020 |
Why?
|
| Biological Factors | 1 | 1990 | 166 | 0.020 |
Why?
|
| Vitamin A Deficiency | 1 | 1989 | 101 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 431 | 0.020 |
Why?
|
| Ear | 2 | 1982 | 173 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6542 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2011 | 850 | 0.020 |
Why?
|
| Genes, Recessive | 1 | 2011 | 643 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1773 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 802 | 0.020 |
Why?
|
| Fever of Unknown Origin | 1 | 1989 | 99 | 0.020 |
Why?
|
| Aorta | 1 | 1996 | 2063 | 0.020 |
Why?
|
| Pathology, Surgical | 1 | 2009 | 155 | 0.020 |
Why?
|
| Blood | 2 | 2002 | 593 | 0.020 |
Why?
|
| Central Nervous System | 2 | 1987 | 1362 | 0.020 |
Why?
|
| Synovial Membrane | 2 | 1988 | 518 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 836 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1343 | 0.020 |
Why?
|
| Complement Fixation Tests | 1 | 1987 | 78 | 0.020 |
Why?
|
| Carrageenan | 1 | 2007 | 67 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 2007 | 41 | 0.020 |
Why?
|
| Therapeutic Irrigation | 2 | 1986 | 302 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1779 | 0.020 |
Why?
|
| Ureter | 2 | 2001 | 375 | 0.020 |
Why?
|
| Immunologic Capping | 1 | 1987 | 31 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 901 | 0.020 |
Why?
|
| HMGB1 Protein | 1 | 2009 | 136 | 0.020 |
Why?
|
| DNA | 3 | 1992 | 7312 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 2121 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1346 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 2260 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 412 | 0.020 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2008 | 171 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1990 | 1453 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2019 | 4248 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2011 | 1155 | 0.020 |
Why?
|
| Serine | 1 | 2011 | 825 | 0.020 |
Why?
|
| Genome, Human | 1 | 2020 | 4446 | 0.020 |
Why?
|
| Factor XIII | 1 | 1987 | 59 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 839 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 767 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 1800 | 0.020 |
Why?
|
| Child | 4 | 2010 | 78594 | 0.020 |
Why?
|
| Cell Fusion | 1 | 1987 | 296 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2002 | 3164 | 0.020 |
Why?
|
| Thiocyanates | 1 | 1986 | 71 | 0.020 |
Why?
|
| Submandibular Gland | 1 | 2006 | 86 | 0.020 |
Why?
|
| Docosahexaenoic Acids | 1 | 1993 | 888 | 0.020 |
Why?
|
| Transduction, Genetic | 2 | 2001 | 905 | 0.020 |
Why?
|
| Histiocytes | 1 | 1987 | 102 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2014 | 2049 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2313 | 0.020 |
Why?
|
| Abortion, Spontaneous | 1 | 2012 | 546 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1986 | 235 | 0.020 |
Why?
|
| Granzymes | 1 | 2008 | 271 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1986 | 225 | 0.020 |
Why?
|
| Mitogens | 2 | 1984 | 232 | 0.020 |
Why?
|
| Random Allocation | 1 | 1991 | 2426 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1987 | 647 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1917 | 0.020 |
Why?
|
| Monitoring, Physiologic | 3 | 2006 | 1750 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1992 | 1074 | 0.020 |
Why?
|
| Cytotoxicity Tests, Immunologic | 3 | 2000 | 329 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2011 | 727 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 3860 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 1986 | 424 | 0.020 |
Why?
|
| Recurrence | 2 | 2008 | 8422 | 0.020 |
Why?
|
| Models, Biological | 3 | 2012 | 9569 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2019 | 12202 | 0.020 |
Why?
|
| Massachusetts | 3 | 2001 | 8721 | 0.020 |
Why?
|
| Herpes Simplex | 2 | 1986 | 473 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1989 | 543 | 0.020 |
Why?
|
| Hybrid Cells | 2 | 1997 | 435 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5149 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 1984 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 1353 | 0.020 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2006 | 277 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2011 | 1273 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6364 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 4228 | 0.020 |
Why?
|
| Natural Killer T-Cells | 1 | 2008 | 314 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1984 | 2253 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2711 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2001 | 673 | 0.020 |
Why?
|
| Plasmacytoma | 1 | 2006 | 177 | 0.020 |
Why?
|
| Phospholipids | 1 | 1989 | 785 | 0.020 |
Why?
|
| Labyrinth Supporting Cells | 1 | 2004 | 13 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2014 | 2614 | 0.020 |
Why?
|
| HIV Infections | 2 | 2010 | 16882 | 0.020 |
Why?
|
| Lipids | 1 | 1996 | 3326 | 0.020 |
Why?
|
| Histamine | 2 | 1984 | 509 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1984 | 179 | 0.020 |
Why?
|
| Ferritins | 2 | 1985 | 590 | 0.020 |
Why?
|
| Basilar Membrane | 1 | 2004 | 50 | 0.020 |
Why?
|
| Fibrinolysis | 3 | 1998 | 327 | 0.020 |
Why?
|
| Aorta, Abdominal | 1 | 1988 | 641 | 0.020 |
Why?
|
| Calcium | 2 | 2001 | 5774 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 1690 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 5144 | 0.020 |
Why?
|
| Gels | 1 | 1986 | 425 | 0.020 |
Why?
|
| Kidney Concentrating Ability | 1 | 1984 | 41 | 0.020 |
Why?
|
| Combined Modality Therapy | 3 | 2008 | 8660 | 0.020 |
Why?
|
| Organ of Corti | 1 | 2004 | 85 | 0.020 |
Why?
|
| Ketorolac Tromethamine | 1 | 2004 | 21 | 0.020 |
Why?
|
| Esterases | 1 | 1984 | 96 | 0.020 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2004 | 115 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 1988 | 550 | 0.020 |
Why?
|
| Gestational Age | 2 | 1984 | 3555 | 0.020 |
Why?
|
| Thyroiditis | 1 | 1985 | 85 | 0.020 |
Why?
|
| Rheumatoid Factor | 1 | 1985 | 190 | 0.010 |
Why?
|
| Alprostadil | 1 | 2004 | 89 | 0.010 |
Why?
|
| Chromosomes | 1 | 1987 | 601 | 0.010 |
Why?
|
| Collagen Type IV | 1 | 2004 | 139 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2004 | 384 | 0.010 |
Why?
|
| Liver | 2 | 1998 | 7538 | 0.010 |
Why?
|
| Troponin T | 1 | 2008 | 766 | 0.010 |
Why?
|
| Plasmapheresis | 1 | 2004 | 203 | 0.010 |
Why?
|
| Immune System | 1 | 2009 | 812 | 0.010 |
Why?
|
| Actins | 1 | 2011 | 2114 | 0.010 |
Why?
|
| Cell Membrane | 4 | 1979 | 3746 | 0.010 |
Why?
|
| Diabetes Insipidus | 1 | 1984 | 150 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2011 | 2746 | 0.010 |
Why?
|
| Descemet Membrane | 1 | 1984 | 72 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2019 | 6567 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2006 | 664 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1983 | 25 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2016 | 3487 | 0.010 |
Why?
|
| Genomics | 1 | 2019 | 5743 | 0.010 |
Why?
|
| Cystadenocarcinoma | 1 | 1983 | 55 | 0.010 |
Why?
|
| Bone Marrow Cells | 3 | 2001 | 2491 | 0.010 |
Why?
|
| Transplantation, Heterotopic | 1 | 2003 | 177 | 0.010 |
Why?
|
| Coronary Angiography | 1 | 2015 | 4598 | 0.010 |
Why?
|
| Heparin | 2 | 2004 | 1653 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 601 | 0.010 |
Why?
|
| Encephalitis | 1 | 1986 | 429 | 0.010 |
Why?
|
| Chromosomes, Human, X | 1 | 2004 | 296 | 0.010 |
Why?
|
| Cystadenoma | 1 | 1983 | 85 | 0.010 |
Why?
|
| Indoles | 1 | 2011 | 1839 | 0.010 |
Why?
|
| Diploidy | 2 | 1992 | 138 | 0.010 |
Why?
|
| Meninges | 1 | 1984 | 191 | 0.010 |
Why?
|
| Protein Binding | 2 | 2009 | 9408 | 0.010 |
Why?
|
| Rats, Inbred BN | 4 | 1988 | 235 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2004 | 596 | 0.010 |
Why?
|
| Educational Measurement | 1 | 1989 | 1221 | 0.010 |
Why?
|
| Arthritis, Experimental | 1 | 1985 | 291 | 0.010 |
Why?
|
| Gadolinium | 1 | 2007 | 959 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1988 | 3766 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1985 | 205 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1262 | 0.010 |
Why?
|
| Chemokine CXCL11 | 1 | 2001 | 43 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2006 | 819 | 0.010 |
Why?
|
| Long-Term Care | 2 | 1982 | 611 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1983 | 184 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 1984 | 421 | 0.010 |
Why?
|
| Fas Ligand Protein | 1 | 2002 | 216 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 20346 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1983 | 278 | 0.010 |
Why?
|
| Peritoneal Dialysis | 1 | 2002 | 148 | 0.010 |
Why?
|
| Sarcoma | 1 | 1992 | 1903 | 0.010 |
Why?
|
| Uveitis | 1 | 1985 | 381 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 11626 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4733 | 0.010 |
Why?
|
| Ribavirin | 1 | 2003 | 393 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 1990 | 804 | 0.010 |
Why?
|
| Software | 1 | 2015 | 4460 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2012 | 3802 | 0.010 |
Why?
|
| Rats, Inbred Lew | 4 | 1988 | 1172 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2007 | 2633 | 0.010 |
Why?
|
| Macaca mulatta | 2 | 1998 | 2389 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2001 | 240 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 1984 | 672 | 0.010 |
Why?
|
| Chemokine CXCL10 | 1 | 2001 | 318 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2423 | 0.010 |
Why?
|
| Glucose | 1 | 2012 | 4396 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 1988 | 1049 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8607 | 0.010 |
Why?
|
| Tears | 1 | 1981 | 262 | 0.010 |
Why?
|
| Hematuria | 2 | 1998 | 234 | 0.010 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2004 | 658 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2008 | 7708 | 0.010 |
Why?
|
| Pancreas | 1 | 2006 | 1704 | 0.010 |
Why?
|
| Natriuresis | 1 | 1999 | 124 | 0.010 |
Why?
|
| Chemokines, CXC | 1 | 2001 | 425 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1731 | 0.010 |
Why?
|
| Heterozygote | 1 | 1986 | 2816 | 0.010 |
Why?
|
| C-Peptide | 1 | 2001 | 425 | 0.010 |
Why?
|
| Pregnancy | 3 | 2012 | 29630 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 1984 | 4062 | 0.010 |
Why?
|
| Insulin | 2 | 2001 | 6623 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1987 | 1919 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1979 | 297 | 0.010 |
Why?
|
| Immunotoxins | 1 | 1999 | 178 | 0.010 |
Why?
|
| Papain | 1 | 1978 | 64 | 0.010 |
Why?
|
| Cause of Death | 1 | 2009 | 3628 | 0.010 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1999 | 133 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 1998 | 41 | 0.010 |
Why?
|
| Genes | 2 | 1988 | 1885 | 0.010 |
Why?
|
| Binding Sites | 2 | 1979 | 6118 | 0.010 |
Why?
|
| Perforin | 1 | 1999 | 169 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1998 | 79 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1987 | 1788 | 0.010 |
Why?
|
| Sulfones | 1 | 2001 | 436 | 0.010 |
Why?
|
| Diphtheria Toxin | 1 | 1999 | 254 | 0.010 |
Why?
|
| Albumins | 1 | 1981 | 564 | 0.010 |
Why?
|
| Brain | 2 | 2022 | 26598 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2950 | 0.010 |
Why?
|
| Sclerosis | 1 | 1999 | 215 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2003 | 909 | 0.010 |
Why?
|
| Surface Properties | 1 | 1981 | 1182 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 2 | 1989 | 378 | 0.010 |
Why?
|
| Visual Acuity | 1 | 1987 | 2603 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 1994 | 0.010 |
Why?
|
| Hypertension, Renal | 1 | 1998 | 176 | 0.010 |
Why?
|
| Ovary | 1 | 1983 | 983 | 0.010 |
Why?
|
| Erythema | 1 | 1979 | 261 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1977 | 163 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1978 | 209 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23554 | 0.010 |
Why?
|
| Hemoperfusion | 1 | 1997 | 14 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 2471 | 0.010 |
Why?
|
| Blood-Brain Barrier | 1 | 1984 | 1017 | 0.010 |
Why?
|
| Hemangioma | 1 | 1982 | 744 | 0.010 |
Why?
|
| Warts | 1 | 1977 | 69 | 0.010 |
Why?
|
| Stromal Cells | 1 | 2003 | 1349 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1981 | 1035 | 0.010 |
Why?
|
| Telemedicine | 1 | 1994 | 2990 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1982 | 514 | 0.010 |
Why?
|
| Leukopenia | 1 | 1977 | 213 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 318 | 0.010 |
Why?
|
| Fetal Proteins | 1 | 1977 | 97 | 0.010 |
Why?
|
| Solubility | 1 | 1978 | 1091 | 0.010 |
Why?
|
| Depressive Disorder | 1 | 1990 | 3759 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2002 | 2304 | 0.010 |
Why?
|
| Reoperation | 2 | 1997 | 4248 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2001 | 721 | 0.010 |
Why?
|
| Cysts | 1 | 2002 | 686 | 0.010 |
Why?
|
| Blood Cells | 2 | 1975 | 310 | 0.010 |
Why?
|
| Pancytopenia | 1 | 1997 | 102 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1998 | 425 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1977 | 917 | 0.010 |
Why?
|
| Hepatitis B | 2 | 1983 | 702 | 0.010 |
Why?
|
| Ovalbumin | 2 | 1975 | 723 | 0.010 |
Why?
|
| Blood Glucose | 2 | 2001 | 6318 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1984 | 1417 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 1998 | 383 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1984 | 4943 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2001 | 1848 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 2 | 1999 | 8285 | 0.010 |
Why?
|
| Cytoplasmic Granules | 2 | 1978 | 611 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4179 | 0.010 |
Why?
|
| Epidermal Growth Factor | 2 | 1989 | 703 | 0.010 |
Why?
|
| Enalapril | 1 | 1997 | 327 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1995 | 189 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 16789 | 0.010 |
Why?
|
| Serum Albumin, Radio-Iodinated | 1 | 1975 | 37 | 0.010 |
Why?
|
| Dinitrochlorobenzene | 1 | 1975 | 18 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 7355 | 0.010 |
Why?
|
| Ascitic Fluid | 1 | 1975 | 193 | 0.010 |
Why?
|
| Spinal Cord | 1 | 1984 | 1809 | 0.010 |
Why?
|
| United Arab Emirates | 1 | 1994 | 42 | 0.010 |
Why?
|
| Benzene Derivatives | 1 | 1975 | 54 | 0.010 |
Why?
|
| Actuarial Analysis | 1 | 1995 | 378 | 0.010 |
Why?
|
| Cephalothin | 1 | 1974 | 36 | 0.010 |
Why?
|
| Amniotic Fluid | 1 | 1977 | 373 | 0.010 |
Why?
|
| Retroviridae | 1 | 1997 | 914 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2001 | 1603 | 0.010 |
Why?
|
| Chlorobenzenes | 1 | 1974 | 28 | 0.010 |
Why?
|
| Nephrosclerosis | 1 | 1974 | 11 | 0.010 |
Why?
|
| Endometriosis | 1 | 1983 | 842 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5584 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1993 | 6233 | 0.010 |
Why?
|
| Lung Neoplasms | 3 | 1984 | 13263 | 0.010 |
Why?
|
| Arsenicals | 1 | 1975 | 120 | 0.010 |
Why?
|
| Esterification | 1 | 1994 | 36 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13984 | 0.010 |
Why?
|
| Oxacillin | 1 | 1974 | 42 | 0.010 |
Why?
|
| Peptides | 1 | 1986 | 4430 | 0.010 |
Why?
|
| Saudi Arabia | 1 | 1994 | 210 | 0.010 |
Why?
|
| Nephrectomy | 3 | 1982 | 1046 | 0.010 |
Why?
|
| Nephrosis, Lipoid | 1 | 1974 | 49 | 0.010 |
Why?
|
| Ligands | 1 | 2001 | 3300 | 0.010 |
Why?
|
| Tuberculin Test | 1 | 1975 | 214 | 0.010 |
Why?
|
| Biphenyl Compounds | 1 | 1998 | 940 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 1625 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 690 | 0.010 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1998 | 533 | 0.010 |
Why?
|
| Advisory Committees | 1 | 1998 | 779 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1973 | 91 | 0.010 |
Why?
|
| Government Regulation | 1 | 1998 | 524 | 0.010 |
Why?
|
| Serum Albumin | 2 | 1975 | 680 | 0.010 |
Why?
|
| Purpura | 1 | 1974 | 121 | 0.010 |
Why?
|
| Mycobacterium | 1 | 1975 | 249 | 0.010 |
Why?
|
| Transfection | 1 | 2001 | 5882 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1994 | 420 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1994 | 206 | 0.010 |
Why?
|
| Neoplasm Metastasis | 3 | 1992 | 4881 | 0.010 |
Why?
|
| Peroxidases | 1 | 1973 | 139 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1994 | 417 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1994 | 531 | 0.010 |
Why?
|
| Magnesium | 1 | 1975 | 813 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1992 | 172 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1132 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 3123 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 1999 | 1380 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1997 | 1524 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1993 | 593 | 0.010 |
Why?
|
| Tyrosine | 1 | 1975 | 1462 | 0.010 |
Why?
|
| Hepacivirus | 1 | 1997 | 1381 | 0.010 |
Why?
|
| Urethra | 1 | 1992 | 411 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1985 | 3118 | 0.010 |
Why?
|
| United States Food and Drug Administration | 1 | 1998 | 1611 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 1989 | 117 | 0.010 |
Why?
|
| Transforming Growth Factors | 1 | 1989 | 76 | 0.010 |
Why?
|
| Reference Standards | 1 | 1993 | 1021 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 1996 | 1303 | 0.010 |
Why?
|
| Skin Diseases | 1 | 1977 | 1073 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2001 | 2145 | 0.010 |
Why?
|
| Integrins | 1 | 1993 | 850 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 1974 | 1177 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2004 | 4738 | 0.000 |
Why?
|
| Transplantation, Isogeneic | 2 | 1978 | 257 | 0.000 |
Why?
|
| Syndrome | 1 | 1974 | 3261 | 0.000 |
Why?
|
| Immunoelectrophoresis | 1 | 1987 | 110 | 0.000 |
Why?
|
| Rheumatic Diseases | 1 | 1994 | 609 | 0.000 |
Why?
|
| Allergens | 1 | 1974 | 1339 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1999 | 10252 | 0.000 |
Why?
|
| Receptors, IgG | 1 | 1989 | 583 | 0.000 |
Why?
|
| Clinical Protocols | 1 | 1992 | 1463 | 0.000 |
Why?
|
| Warfarin | 1 | 1975 | 1515 | 0.000 |
Why?
|
| Transglutaminases | 1 | 1987 | 188 | 0.000 |
Why?
|
| Smoking | 1 | 1982 | 9030 | 0.000 |
Why?
|
| Prevalence | 1 | 2002 | 15404 | 0.000 |
Why?
|
| Filtration | 1 | 1986 | 233 | 0.000 |
Why?
|
| Hypersensitivity | 1 | 1974 | 1123 | 0.000 |
Why?
|
| Drug Hypersensitivity | 1 | 1974 | 897 | 0.000 |
Why?
|
| Vacuoles | 1 | 1985 | 229 | 0.000 |
Why?
|
| Immunocompetence | 1 | 1985 | 138 | 0.000 |
Why?
|
| Granulocytes | 1 | 1986 | 550 | 0.000 |
Why?
|
| Down-Regulation | 1 | 1992 | 2987 | 0.000 |
Why?
|
| Antibody-Producing Cells | 1 | 1984 | 143 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1992 | 3627 | 0.000 |
Why?
|
| Hepatitis B Antigens | 1 | 1983 | 40 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 2 | 1981 | 7269 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 1796 | 0.000 |
Why?
|
| Thrombin | 1 | 1986 | 599 | 0.000 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1992 | 1370 | 0.000 |
Why?
|
| Hepatitis B Core Antigens | 1 | 1983 | 91 | 0.000 |
Why?
|
| Chemotaxis | 1 | 1986 | 602 | 0.000 |
Why?
|
| Hepatitis B e Antigens | 1 | 1983 | 133 | 0.000 |
Why?
|
| Hepatitis B Antibodies | 1 | 1983 | 160 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1984 | 1676 | 0.000 |
Why?
|
| Chromatin | 1 | 1974 | 2960 | 0.000 |
Why?
|
| Sheep | 2 | 1975 | 1445 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1981 | 249 | 0.000 |
Why?
|
| Rosette Formation | 1 | 1981 | 152 | 0.000 |
Why?
|
| United States | 2 | 2001 | 70772 | 0.000 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1989 | 2002 | 0.000 |
Why?
|
| Eosinophilia | 2 | 1977 | 549 | 0.000 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 9664 | 0.000 |
Why?
|
| DNA Replication | 1 | 1987 | 1407 | 0.000 |
Why?
|
| Rats, Inbred F344 | 1 | 1981 | 862 | 0.000 |
Why?
|
| Radiology | 1 | 1994 | 2131 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1992 | 1890 | 0.000 |
Why?
|
| Infectious Mononucleosis | 1 | 1981 | 133 | 0.000 |
Why?
|
| Bandages | 1 | 1981 | 267 | 0.000 |
Why?
|
| Cytological Techniques | 1 | 1981 | 219 | 0.000 |
Why?
|
| Bacterial Infections | 2 | 1981 | 1401 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1984 | 1534 | 0.000 |
Why?
|
| Intradermal Tests | 1 | 1978 | 44 | 0.000 |
Why?
|
| Genetics, Population | 1 | 1984 | 938 | 0.000 |
Why?
|
| Histamine Release | 1 | 1978 | 142 | 0.000 |
Why?
|
| Sex Factors | 1 | 1972 | 10469 | 0.000 |
Why?
|
| Mycobacterium bovis | 1 | 1978 | 150 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 11091 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1984 | 1270 | 0.000 |
Why?
|
| Trypsin | 1 | 1978 | 509 | 0.000 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1987 | 1395 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1977 | 25903 | 0.000 |
Why?
|
| Infant | 2 | 1992 | 35447 | 0.000 |
Why?
|
| Tissue Extracts | 1 | 1976 | 135 | 0.000 |
Why?
|
| Immune Adherence Reaction | 1 | 1975 | 32 | 0.000 |
Why?
|
| Crosses, Genetic | 1 | 1976 | 791 | 0.000 |
Why?
|
| Dinitrophenols | 1 | 1975 | 57 | 0.000 |
Why?
|
| BCG Vaccine | 1 | 1978 | 371 | 0.000 |
Why?
|
| gamma-Globulins | 1 | 1975 | 124 | 0.000 |
Why?
|
| Ammonium Chloride | 1 | 1974 | 73 | 0.000 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1974 | 314 | 0.000 |
Why?
|
| Klebsiella | 1 | 1974 | 47 | 0.000 |
Why?
|
| Pyuria | 1 | 1974 | 30 | 0.000 |
Why?
|
| Neoplasm Proteins | 1 | 1987 | 3700 | 0.000 |
Why?
|
| Staphylococcus | 1 | 1974 | 155 | 0.000 |
Why?
|
| Blood Sedimentation | 1 | 1974 | 234 | 0.000 |
Why?
|
| Polymorphism, Genetic | 1 | 1984 | 4327 | 0.000 |
Why?
|
| Hemolysis | 1 | 1974 | 429 | 0.000 |
Why?
|
| Magnetics | 1 | 1974 | 605 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1979 | 4723 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1986 | 5725 | 0.000 |
Why?
|
| Immunization | 1 | 1974 | 1254 | 0.000 |
Why?
|
| Iron | 1 | 1974 | 1786 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1975 | 2259 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1975 | 4311 | 0.000 |
Why?
|